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Finite supply of fossil fuels, resource efficiency, carbon footprint. All of them are megatrends within international production 
environments. But how to measure environmental sustainability? What is the environmental impact of your Supply Chain? 
 
Innovative production technologies require cutting edge resource consumption assessment methods, e.g. based on 
thermodynamics. 
Exergy Analysis (EA) at process (α) and plant (β)  level 
Exergetic Life Cycle Analysis (ELCA) at overall industrial level (γ) 
 
 
  
 
 
 
 
 
 
 
 
Sustainability indicators can facilitate the improvement of technologies such as lyophilization by 
quantitatively supporting decision making; leading to new, more efficient and more sustainable 
pharmaceutical production processes. These indicators should look further than the process level, 
taking into consideration the whole life cycle production chain  
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Potential valorisation: 
• Direct cost reduction (26% resource consumption 
reduction)  Lean Manufacturing 
• Corporate Sustainability Reporting 
• Marketing, communications 
• Meeting (European) legislations and voluntary initiatives 
 
Future outlook:  
• Environmental assessment of a batch lyophilization technology versus a (new) continuous lyophilization technology    
 
Results: 
• Continuous processing has proven to be an effective 
approach for process intensification; reducing resource 
consumption in the production site and throughout  the 
overall supply chain 
• For low  dose drugs, the primary packaging phase is an 
important resource contributor. Assessing complex primary 
packaging processes like it is the case of lyophilization can 
lead into significant resource savings 
